Decreased blood-brain barrier P-glycoprotein function with aging

Ítems similars

• Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood–brain barrier
  per: Bauer, Martin, et al.
  Publicat: (2010)
• Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-(11)C-verapamil and PET
  per: Bankstahl, Jens P., et al.
  Publicat: (2008)
• A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of (11)C- and (14)C-labelled verapamil in healthy volunteers
  per: Wagner, Claudia C, et al.
  Publicat: (2008)
• A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)–(11)C-verapamil and PET
  per: Wagner, Claudia C, et al.
  Publicat: (2009)
• Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
  per: Bauer, Martin, et al.
  Publicat: (2010)